SAREGAMA INDIA LTD. ANNUAL REPORT REVIEW

Saregama stretches back over a century to 1901. Formerly known as The Gramophone Company of India Ltd. and more popularly as HMV (His Master’s Voice), Saregama was established as the first overseas Indian Branch of Electrical & Musical Industries Limited (EMI), London. From producing the first song recorded in India in 1902 by the star of yesteryears, Gauhar Jan, to creating strong inroads into the production of cinema and television content, digital retailing, aggregation, radio programming and events, Saregama has evolved into one of India’s premier entertainment content companies.

Annual Report Review FY2015-16, FY2014-15.

Disclaimer: This is not a recommendation to Buy-Sell-Hold. And I am not a SEBI registered analyst.

PIRAMAL ENTERPRISES LIMITED ANNUAL REPORT REVIEW 2015-16

Piramal Group is a diversified conglomerate having three virtual companies – Financial Services (28% revenue contribution), Healthcare (54% revenue contribution) and Information Management (18% revenue contribution).

Company has shown indication for the demerger of businesses in future. Business had done many acquisitions but important is that also sold non-core businesses also. Mr. Ajay Piramal having a good track record with capital allocation, with acquisitions and one of the shareholder friendly promoter.

Annual Report Review FY2015-16, FY2014-15.

Disclaimer: This is not a recommendation to Buy-Sell-Hold. And I am not a SEBI registered analyst.

INDO COUNT INDUSTRIES LTD. ANNUAL REPORT REVIEW 2015-16

Indo Count Industries Ltd. manufacturing  Bed Sheet Sets, Pillow Cases, Duvet covers, Comforters, Window Covering and Hospital Linen. Brand of company presence in all the major markets like UK, Italy, Germany, Switzerland, Scandinavia, Israel, Canada, Chile, Japan, South Korea, etc.

Clients and brand partners of the Indo Count—

Indo Count Industries Ltd. Annual Report Review FY2015-16, FY2014-15, FY2013-14. (Kindly download  Annual Report for reading comments).

Disclaimer: This is not a recommendation to Buy-Sell-Hold. And I am not a SEBI registered analyst.